Share on StockTwits

PDL BioPharma (NASDAQ:PDLI) is set to issue its Q214 quarterly earnings data on Monday, August 11th. Analysts expect the company to announce earnings of $0.46 per share and revenue of $134.07 million for the quarter.

PDL BioPharma (NASDAQ:PDLI) opened at 9.34 on Friday. PDL BioPharma has a 1-year low of $7.38 and a 1-year high of $10.21. The stock’s 50-day moving average is $9.52 and its 200-day moving average is $8.88. The company has a market cap of $1.500 billion and a P/E ratio of 5.44.

PDL BioPharma, Inc (NASDAQ:PDLI) is a is a biotech company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.